Thierry Lavabre‐Bertrand
- Hematology top 5%
- Multiple Myeloma Research and Treatments 5
- Acute Myeloid Leukemia Research 5
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 16
-
- Lymphoma Diagnosis and Treatment 7
- Immunology top 10%
- Immunotherapy and Immune Responses 4
- Oncology top 10%
- Peptidase Inhibition and Analysis 4
-
- Ubiquitin and proteasome pathways 9
-
- Erythrocyte Function and Pathophysiology 5
- Partner nations
- FranceUnited KingdomUnited States
In The Last Decade
Thierry Lavabre‐Bertrand
55 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 85
- Hematology 318
- Genetics 237
- Pathology and Forensic Medicine 293
- Immunology 309
- Oncology 377
Countries citing papers authored by Thierry Lavabre‐Bertrand
This map shows the geographic impact of Thierry Lavabre‐Bertrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Lavabre‐Bertrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Lavabre‐Bertrand more than expected).
Fields of papers citing papers by Thierry Lavabre‐Bertrand
This network shows the impact of papers produced by Thierry Lavabre‐Bertrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Lavabre‐Bertrand. The network helps show where Thierry Lavabre‐Bertrand may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thierry Lavabre‐Bertrand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 5 | |
| 2 | 2021 | 11 | |
| 3 | 2015 | 12 | |
| 4 | 2011 | 28 | |
| 5 | 2011 | 13 | |
| 6 | 2009 | 9 | |
| 7 | 2008 | 3 | |
| 8 | 2005 | 1 | |
| 9 | 2005 | 67 | |
| 10 | 2004 | 26 | |
| 11 | 2001 | 93 | |
| 12 | 2001 | 25 | |
| 13 | 2000 | 16 | |
| 14 | Traitement de la dysérythropoïèse congénitale de type I par l'interféron | 1998 | 1 |
| 15 | 1997 | 114 | |
| 16 | 1996 | 17 | |
| 17 | 1995 | 33 | |
| 18 | 1994 | 12 | |
| 19 | 1993 | 3 | |
| 20 | 1992 | 43 |
About Thierry Lavabre‐Bertrand
Thierry Lavabre‐Bertrand is a scholar working on Genetics, Hematology and Dermatology, having authored 59 papers that have together received 1.4k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (16 papers), Ubiquitin and proteasome pathways (9 papers), Lymphoma Diagnosis and Treatment (7 papers), Erythrocyte Function and Pathophysiology (5 papers), Multiple Myeloma Research and Treatments (5 papers), Acute Myeloid Leukemia Research (5 papers), Immunotherapy and Immune Responses (4 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Hematology (318 citations), Genetics (237 citations) and Pathology and Forensic Medicine (293 citations). Thierry Lavabre‐Bertrand has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include J Brochier, Laurent Henry, Serge Carillo, Bernard Klein, JF Rossi, Tim N. Beck, R Bataille, Lu Zy, Bart Barlogie and G Jánossy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.